TABLE 3.
Effects | CT, HR (95% CI) | CT + B, HR (95% CI) |
---|---|---|
Direct | 0.71 (0.46 to 1.11) | 1.75 (1.10 to 2.77) |
Indirect | 2.05 (1.53 to 2.73) | 1.42 (1.12 to 1.81) |
Total | 1.46 (0.94 to 2.28) | 2.49 (1.54 to 4.03) |
Abbreviations: CT, chemotherapy; CT + B, chemotherapy + bevacizumab; HR, hazard ratio; NLR, neutrophil-to-lymphocyte ratio.